Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF614 for Postoperative Pain After Abdominoplasty
NCT06602271Phase 3Recruiting
- Sponsor
- Ensysce Biosciences
- Start
- Dec 2025
- Primary completion
- Aug 2026
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of PF614 in acute postoperative pain, sponsored by Ensysce Biosciences. Started Dec 2025; status: recruiting.
02
Drugs
PF614
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on NCT06602271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06602271.